Six Sigma in BioPharma - ISPE Boston · - DMAIC - DMADV - DFSS - 3.4 DPMO - C p, C pk - Control ......

28
Six Sigma in BioPharma Niranjan S. Kulkarni, PhD CRB Consulting Engineers

Transcript of Six Sigma in BioPharma - ISPE Boston · - DMAIC - DMADV - DFSS - 3.4 DPMO - C p, C pk - Control ......

Page 1: Six Sigma in BioPharma - ISPE Boston · - DMAIC - DMADV - DFSS - 3.4 DPMO - C p, C pk - Control ... •Process variability vs. flow variability ... DMAIC is not well suited for some

Six Sigma in BioPharma

Niranjan S. Kulkarni, PhD CRB Consulting Engineers

Page 2: Six Sigma in BioPharma - ISPE Boston · - DMAIC - DMADV - DFSS - 3.4 DPMO - C p, C pk - Control ... •Process variability vs. flow variability ... DMAIC is not well suited for some

• Introduction to Six Sigma

• Categorizing Six Sigma Techniques

• Take-Away

Agenda

Page 3: Six Sigma in BioPharma - ISPE Boston · - DMAIC - DMADV - DFSS - 3.4 DPMO - C p, C pk - Control ... •Process variability vs. flow variability ... DMAIC is not well suited for some

Lean and Six Sigma

Lean Methodology “As-Is Flow” “To-Be Flow”

Increase efficiency

Simplify work flows

Focus on high-value steps

Eliminate waste

A Lean enterprise is one that delivers value to its

stakeholders with little or no wasteful consumption of

resources.

Product or Service Outputs

Six Sigma Methodologies

Increase consistency

Reduce variation

Eliminate defects

In a Six Sigma enterprise, everyone is focused on identifying

and eliminating defects.

Customer-driven Customer-driven

Page 4: Six Sigma in BioPharma - ISPE Boston · - DMAIC - DMADV - DFSS - 3.4 DPMO - C p, C pk - Control ... •Process variability vs. flow variability ... DMAIC is not well suited for some

Introduction to Six Sigma

Page 5: Six Sigma in BioPharma - ISPE Boston · - DMAIC - DMADV - DFSS - 3.4 DPMO - C p, C pk - Control ... •Process variability vs. flow variability ... DMAIC is not well suited for some

• Sigma (σ) – Standard deviation

Introduction to Six Sigma

Kubiak and Benbow, 2009

Philosophy Methodology Metrics Set of Tools

- Control the process, control the output

- Y = f(Xs)

- DMAIC - DMADV - DFSS

- 3.4 DPMO - Cp, Cpk

- Control charts

- FMEA - DOEs - Etc.

Variation & Defect Reduction

Page 6: Six Sigma in BioPharma - ISPE Boston · - DMAIC - DMADV - DFSS - 3.4 DPMO - C p, C pk - Control ... •Process variability vs. flow variability ... DMAIC is not well suited for some

• Types of variability

– Temporal

–Material

–Measurement

– Spatial

– Behavior

Introduction to Six Sigma (cont’d)

Page 7: Six Sigma in BioPharma - ISPE Boston · - DMAIC - DMADV - DFSS - 3.4 DPMO - C p, C pk - Control ... •Process variability vs. flow variability ... DMAIC is not well suited for some

• Process variability vs. flow variability

Introduction to Six Sigma (cont’d)

Avg. Lead Time

Process

variability

Flow variability

Page 8: Six Sigma in BioPharma - ISPE Boston · - DMAIC - DMADV - DFSS - 3.4 DPMO - C p, C pk - Control ... •Process variability vs. flow variability ... DMAIC is not well suited for some

• Increased variability increases effective cycle time

• Higher variability degrades system performance

• Systems with variability have to be buffered (Hopp and

Spearman, 2011)

– Time

– Capacity

– Inventory

Introduction to Six Sigma (cont’d)

ope TTUVCT

eCTTHWIP

Page 9: Six Sigma in BioPharma - ISPE Boston · - DMAIC - DMADV - DFSS - 3.4 DPMO - C p, C pk - Control ... •Process variability vs. flow variability ... DMAIC is not well suited for some

Categorizing Six Sigma Techniques

Page 10: Six Sigma in BioPharma - ISPE Boston · - DMAIC - DMADV - DFSS - 3.4 DPMO - C p, C pk - Control ... •Process variability vs. flow variability ... DMAIC is not well suited for some

• Six Sigma techniques can enable various degrees of

understanding variability at following levels:

– Descriptive

–Quantifying / Predictive

– Control

– Behavioral

Six Sigma Techniques

Page 11: Six Sigma in BioPharma - ISPE Boston · - DMAIC - DMADV - DFSS - 3.4 DPMO - C p, C pk - Control ... •Process variability vs. flow variability ... DMAIC is not well suited for some

• Histogram

• Stem & Leaf plot

• Box plots

• Gage R&R

• Etc.

Descriptive Techniques

Stem Leaf

1 2, 3, 7

2 1, 3, 3, 4, 7

3 0, 3, 9

4 5, 6

5 00-10 11-20 21-30 31-40 41-50 51+

0

3

5

3

2

0

Page 12: Six Sigma in BioPharma - ISPE Boston · - DMAIC - DMADV - DFSS - 3.4 DPMO - C p, C pk - Control ... •Process variability vs. flow variability ... DMAIC is not well suited for some

• Lengthy and highly variable changeover time impacted throughput

• 35% reduction in changeover times

Case Study – Descriptive Techniques

Page 13: Six Sigma in BioPharma - ISPE Boston · - DMAIC - DMADV - DFSS - 3.4 DPMO - C p, C pk - Control ... •Process variability vs. flow variability ... DMAIC is not well suited for some

• Design of Experiments

• Simulations

• Statistical and Probabilistic approaches

Quantifying / Predictive Techniques

X

Y

Z

X

Y

+ +

- -

2k Factorial Design

k = 2 k = 3

Page 14: Six Sigma in BioPharma - ISPE Boston · - DMAIC - DMADV - DFSS - 3.4 DPMO - C p, C pk - Control ... •Process variability vs. flow variability ... DMAIC is not well suited for some

Typical Process Simulation Outputs Feasible Schedule Inventory Sizing

Equipment Utilization

Utilities Consumption

Page 15: Six Sigma in BioPharma - ISPE Boston · - DMAIC - DMADV - DFSS - 3.4 DPMO - C p, C pk - Control ... •Process variability vs. flow variability ... DMAIC is not well suited for some

Typical DES Outputs

24%41%

17%18%

DES Model Snapshot Pareto Analysis to Understand Utilization

Headcount Requirements for Changing Demands Utilization Charts Capturing Different States

Page 16: Six Sigma in BioPharma - ISPE Boston · - DMAIC - DMADV - DFSS - 3.4 DPMO - C p, C pk - Control ... •Process variability vs. flow variability ... DMAIC is not well suited for some

• Given the constraints, recommend strategies to improve efficiency and throughput

• Increase in throughput

– Manufacturing (#

Batches) by 60%

– QC Labs (# Tests) by

43%

Case Study 1 – Quantifying Techniques

Page 17: Six Sigma in BioPharma - ISPE Boston · - DMAIC - DMADV - DFSS - 3.4 DPMO - C p, C pk - Control ... •Process variability vs. flow variability ... DMAIC is not well suited for some

Case Study 1 – Quantifying Techniques

Scenario – Increased throughput

Scenario – Base case

Page 18: Six Sigma in BioPharma - ISPE Boston · - DMAIC - DMADV - DFSS - 3.4 DPMO - C p, C pk - Control ... •Process variability vs. flow variability ... DMAIC is not well suited for some

• Identify variability inducing processes affecting quality of finished product

• Predictive model

• Capture probability of conformance

• Helped readjust process mean and develop sampling plan

Case Study 2 – Predictive Techniques

𝑃 𝑎 ≤ 𝑥 ≤ 𝑏 = Φ𝑏−𝜇

𝜎 - Φ

𝑎−𝜇

𝜎

Ideal Process Mean

Original process mean

Adjusted process mean

Page 19: Six Sigma in BioPharma - ISPE Boston · - DMAIC - DMADV - DFSS - 3.4 DPMO - C p, C pk - Control ... •Process variability vs. flow variability ... DMAIC is not well suited for some

• Process monitoring and control charts

• Process capability indices

Control Techniques

Page 20: Six Sigma in BioPharma - ISPE Boston · - DMAIC - DMADV - DFSS - 3.4 DPMO - C p, C pk - Control ... •Process variability vs. flow variability ... DMAIC is not well suited for some

• High fallout rate observed when raw material lot changed

• Raw material variability suspected

• Control charting to understand between lots OD variation

• Poor process capability revealed

• Adjustments initiated at supplier’s end

Case Study – Control Techniques

39153480304526102175174013058704351

0.450

0.425

0.400

0.375

0.350

Index

OD

av

g

Lot 8 start Lot 9 start Lot 10 startLot 7 start

Time Series Plot of OD avg

Page 21: Six Sigma in BioPharma - ISPE Boston · - DMAIC - DMADV - DFSS - 3.4 DPMO - C p, C pk - Control ... •Process variability vs. flow variability ... DMAIC is not well suited for some

• Behavior characteristics

– Behavior is an erratic, dynamic, continuous phenomenon

– Behavioral variability is a result of intrinsic / extrinsic

environmental influence

– Individual’s behavior may (or may not) be different than the

group’s behavior

Behavioral Techniques

Page 22: Six Sigma in BioPharma - ISPE Boston · - DMAIC - DMADV - DFSS - 3.4 DPMO - C p, C pk - Control ... •Process variability vs. flow variability ... DMAIC is not well suited for some

• Averaging responses of individual subjects within large groups not recommended – random nature of variability is cancelled out

• Capturing behavioral variability

– Three main concepts

» Basic Probability Assignment

» Belief (b)

» Plausibility (p) – Providing imprecise probability of an event

P(A) = [b, p]

Behavioral Techniques (cont’d)

Page 23: Six Sigma in BioPharma - ISPE Boston · - DMAIC - DMADV - DFSS - 3.4 DPMO - C p, C pk - Control ... •Process variability vs. flow variability ... DMAIC is not well suited for some

• FMEA for NPI

• Based on expert opinions only

• Combining responses

• Ranking failures modes

Case Study – Behavioral Techniques

Kulkarni and Johnson, 2012

Page 24: Six Sigma in BioPharma - ISPE Boston · - DMAIC - DMADV - DFSS - 3.4 DPMO - C p, C pk - Control ... •Process variability vs. flow variability ... DMAIC is not well suited for some

Take-Away

Page 25: Six Sigma in BioPharma - ISPE Boston · - DMAIC - DMADV - DFSS - 3.4 DPMO - C p, C pk - Control ... •Process variability vs. flow variability ... DMAIC is not well suited for some

Let’s use Six Sigma for everything!?!

Manufacturing

Supply Chain, Warehousing

Customer Service, Administrative Functions

Research and Development

Marketing and Sales

The reason: DMAIC is not well suited for some parts of the organization

Ramakrishnan, et al., 2007

Page 26: Six Sigma in BioPharma - ISPE Boston · - DMAIC - DMADV - DFSS - 3.4 DPMO - C p, C pk - Control ... •Process variability vs. flow variability ... DMAIC is not well suited for some

We Touched Just The Surface…

Processes

Technologies Tools and Techniques

Strategy and Alignment

Leadership

Behavior and Engagement

Visible

Enabling

Hines, et al., 2008

• We just discussed the ‘visible’ things

• Improving operations may necessitate cultural changes

Page 27: Six Sigma in BioPharma - ISPE Boston · - DMAIC - DMADV - DFSS - 3.4 DPMO - C p, C pk - Control ... •Process variability vs. flow variability ... DMAIC is not well suited for some

Don’t Forget the Human Element!

Page 28: Six Sigma in BioPharma - ISPE Boston · - DMAIC - DMADV - DFSS - 3.4 DPMO - C p, C pk - Control ... •Process variability vs. flow variability ... DMAIC is not well suited for some

Thank You

Niranjan S. Kulkarni • Sr. Operations Specialist

• CRB Consulting Engineers

[email protected]

• 617-475-3073